The TUXEDO-3 trial is the first study to evaluate the intracranial and extracranial efficacy and safety of a novel ...

Patients in a clinical trail of a drug used to treat advanced head and neck cancer lived an average of 2.5 years longer ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

Scientists say these small health issues might be an early sign of lung cancer - As the NHS offers ‘revolutionary’ blood test ...

When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...

Diagnosed with colorectal cancer, Mdm Kris Chow found hope and resilience through the support of her family and medical team ...

A new study employing novel single-cell multimodal data revealed key insights into the tumor microenvironment predictive of NSCLC treatment response.

A therapy at the center of their $22 billion alliance failed to extend survival in a type of lung tumor, leading the ...

A cancer biologist explains the broad harmful effects of alcohol on your health, and how it is the third-leading preventable ...

On Aug. 9, 1945, U.S. forces detonated an atomic bomb over Nagasaki. Shiroyama Elementary School was only 500 meters (1,600 ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...